Machine learning based development of an early diagnosis signature for distinguishing hospitalized pediatric human respiratory syncytial virus infection from mycoplasma pneumonia - Summary - MDSpire

Machine learning based development of an early diagnosis signature for distinguishing hospitalized pediatric human respiratory syncytial virus infection from mycoplasma pneumonia

  • By

  • Xiandan Chen

  • Linlu Ying

  • Weixing Kong

  • Wangxiong Hu

  • Zhong Hu

  • June 2, 2026

  • 0 min

Share

Objective:

To develop and validate a blood-based biomarker signature for distinguishing HRSV from MP infections.

Key Findings:
  • A five-biomarker signature was identified: eosinophilic granulocyte, immunoglobulin A, lactic dehydrogenase (LDH), β2-microglobulin, and albumin to globulin ratio (AGR).
  • The optimized random forest model achieved an AUC-ROC of 0.89 (95% CI: 0.85–0.90) for distinguishing HRSV from MP.
Interpretation:

Remove unsupported claims about clinical management.

Limitations:
  • 1
Conclusion:

Remove implications about clinical utility.

Original Source(s)

Machine learning based development of an early diagnosis signature for distinguishing hospitalized pediatric human respiratory syncytial virus infection from mycoplasma pneumonia

  • by Xiandan Chen, Linlu Ying, Weixing Kong, Wangxiong Hu, Zhong Hu

  • June 2, 2026

Related Content

Pediatric Clinical Images Without Consent: A Governance Gap in the Long-Term Reuse of Health Data in Digital Health Ecosystems

Duodenal ulcer perforation presenting as acute appendicitis in a child: a case report and literature review

Perioperative anesthetic considerations and outcomes in Crouzon syndrome: a retrospective analysis of Le Fort III advancement surgery